[{"NetIncomeLoss_1_Q1_USD":-50447000.0,"RepaymentsOfDebtAndCapitalLeaseObligations_1_Q1_USD":0.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":18000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":9218000.0,"Depreciation_1_Q1_USD":229000.0,"AssetsCurrent_0_Q1_USD":931897000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":7369510.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":1483000.0,"CommonStockSharesIssued_0_Q1_shares":51225861.0,"Assets_0_Q1_USD":1032734000.0,"ShareBasedCompensation_1_Q1_USD":9925000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":72054000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":-119000.0,"CommonStockSharesAuthorized_0_Q1_shares":490000000.0,"AccruedLiabilitiesCurrent_0_Q1_USD":24075000.0,"CommitmentsAndContingencies_0_Q1_USD":null,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":51573909.0,"GeneralAndAdministrativeExpense_1_Q1_USD":10221000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_1_Q1_USD":-35000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":-32000.0,"CommonStockValue_0_Q1_USD":5000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":1472000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_1_Q1_USD":16000000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q1_USD":929000000.0,"DebtSecuritiesAvailableForSaleRealizedGainLoss_1_Q1_USD":0.0,"OperatingIncomeLoss_1_Q1_USD":-50558000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-50482000.0,"OtherAssetsNoncurrent_0_Q1_USD":15152000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":920461000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":75851000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":1163328000.0,"Liabilities_0_Q1_USD":211057000.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"MarketableSecuritiesCurrent_0_Q1_USD":8524000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":-165000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":40337000.0,"OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale_1_Q1_USD":0.0,"InvestmentIncomeInterest_1_Q1_USD":149000.0,"PaymentsToAcquireMarketableSecurities_1_Q1_USD":0.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q1_USD":-35000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":9925000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-34625000.0,"LiabilitiesCurrent_0_Q1_USD":35058000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_1_Q1_USD":-23935000.0,"AccountsPayableCurrent_0_Q1_USD":9176000.0,"InterestExpense_1_Q1_USD":6000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":2912000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":1483000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":1102000.0,"IncreaseDecreaseInOtherOperatingAssets_1_Q1_USD":-603000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q1_USD":926785000.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":7307000.0,"RestrictedCashNoncurrent_0_Q1_USD":6324000.0,"NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_1_Q1_USD":1966000.0,"CommonStockSharesOutstanding_0_Q1_shares":51225861.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-341674000.0,"PreferredStockValue_0_Q1_USD":null,"LiabilitiesAndStockholdersEquity_0_Q1_USD":1032734000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":2574000.0,"PreferredStockSharesAuthorized_0_Q1_shares":10000000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":9925000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q1_USD":100000000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":1807000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q1_USD":8524000.0,"OperatingExpenses_1_Q1_USD":50558000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1_Q1_USD":335000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.98,"OtherLiabilitiesNoncurrent_0_Q1_USD":245000.0,"StockholdersEquity_0_Q1_USD":821677000.0,"DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_0_Q1_USD":0.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":1237000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_1_Q1_USD":-19000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_1_Q1_USD":3205000.0,"AccruedProfessionalFeesCurrent_0_Q1_USD":226000.0,"Ticker":"KOD","CIK":"1468748","name":"KODIAK SCIENCES INC.","OfficialName":"Kodiak Sciences Inc Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"350038530.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210510"}]